SNT 4.76% 4.0¢ syntara limited

the remaining positives, page-22

  1. 2,247 Posts.
    lightbulb Created with Sketch. 298
    Please note, it takes years to develop a drug. PXS made a decision to discontinue development of BI 146..for NASH would be a well thought-out decision.

    There wouldn't be any news from PXS for a while after this sad news. So, wait for another six to eight months for PXS to line-up a new strategy.

    Until then PXS would likely to drop down to 6 c or 7 c.

    So, I wouldn't buy now!
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.